122 related articles for article (PubMed ID: 16044003)
21. R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy.
Delobel P; Sandres-Sauné K; Cazabat M; Pasquier C; Marchou B; Massip P; Izopet J
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):382-92. PubMed ID: 15764954
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals.
Pollakis G; Abebe A; Kliphuis A; Chalaby MI; Bakker M; Mengistu Y; Brouwer M; Goudsmit J; Schuitemaker H; Paxton WA
J Virol; 2004 Mar; 78(6):2841-52. PubMed ID: 14990703
[TBL] [Abstract][Full Text] [Related]
24. Persistence and emergence of X4 virus in HIV infection.
Weinberger AD; Perelson AS
Math Biosci Eng; 2011 Apr; 8(2):605-26. PubMed ID: 21631149
[TBL] [Abstract][Full Text] [Related]
25. Enhanced replication of R5 HIV-1 over X4 HIV-1 in CD4(+)CCR5(+)CXCR4(+) T cells.
Roy AM; Schweighardt B; Eckstein LA; Goldsmith MA; McCune JM
J Acquir Immune Defic Syndr; 2005 Nov; 40(3):267-75. PubMed ID: 16249699
[TBL] [Abstract][Full Text] [Related]
26. Increased number of CCR5+ CD4 T cells among south Indian adults probably associated with the low frequency of X4 phenotype of HIV-1 in India.
Ramalingam S; Kannangai R; Vijayakumar TS; Subramanian S; Abraham OC; Rupali P; Jesudason MV; Sridharan G
Indian J Med Res; 2002 Sep; 116():90-5. PubMed ID: 12619446
[TBL] [Abstract][Full Text] [Related]
27. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
Blanco J; Barretina J; Clotet B; Esté JA
J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
[TBL] [Abstract][Full Text] [Related]
28. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
[TBL] [Abstract][Full Text] [Related]
29. CCR5 and CXCR4 expression correlated with X4 and R5 HIV-1 infection yet not sustained replication in Th1 and Th2 cells.
Moonis M; Lee B; Bailer RT; Luo Q; Montaner LJ
AIDS; 2001 Oct; 15(15):1941-9. PubMed ID: 11600821
[TBL] [Abstract][Full Text] [Related]
30. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
31. Enhanced expression of the CXCR4 co-receptor in HIV-1-infected individuals correlates with the emergence of syncytia-inducing strains.
Manetti R; Cosmi L; Galli G; Annunziato F; Mazzetti M; Romagnani S; Maggi E
Cytokines Cell Mol Ther; 2000 Mar; 6(1):19-24. PubMed ID: 10976535
[TBL] [Abstract][Full Text] [Related]
32. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.
Ghaffari G; Tuttle DL; Briggs D; Burkhardt BR; Bhatt D; Andiman WA; Sleasman JW; Goodenow MM
J Virol; 2005 Nov; 79(21):13250-61. PubMed ID: 16227248
[TBL] [Abstract][Full Text] [Related]
33. Co-receptor switch during HAART is independent of virological success.
Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
[TBL] [Abstract][Full Text] [Related]
34. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
[TBL] [Abstract][Full Text] [Related]
35. Humanized mice dually challenged with R5 and X4 HIV-1 show preferential R5 viremia and restricted X4 infection of CCR5(+)CD4(+) T cells.
Terahara K; Ishige M; Ikeno S; Okada S; Kobayashi-Ishihara M; Ato M; Tsunetsugu-Yokota Y
Microbes Infect; 2015 May; 17(5):378-86. PubMed ID: 25839960
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1.
Bader J; Däumer M; Schöni-Affolter F; Böni J; Gorgievski-Hrisoho M; Martinetti G; Thielen A; Klimkait T;
Clin Infect Dis; 2017 Feb; 64(3):295-300. PubMed ID: 27838645
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells.
Campbell GR; Loret EP; Spector SA
J Biol Chem; 2010 Jan; 285(3):1681-91. PubMed ID: 19917610
[TBL] [Abstract][Full Text] [Related]
38. Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.
Bunnik EM; Quakkelaar ED; van Nuenen AC; Boeser-Nunnink B; Schuitemaker H
J Virol; 2007 Jan; 81(2):525-31. PubMed ID: 17079299
[TBL] [Abstract][Full Text] [Related]
39. Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation.
Hazenberg MD; Otto SA; Hamann D; Roos MT; Schuitemaker H; de Boer RJ; Miedema F
AIDS; 2003 Jul; 17(10):1419-24. PubMed ID: 12824778
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of R5 and X4 HIV variants in antiretroviral treatment experienced patients with virologic failure.
Ferrer P; Tello M; Montecinos L; Tordecilla R; Rodríguez C; Beltrán C; Guzmán MA; Ferrés M; Pérez CM; Afani A
J Clin Virol; 2014 Jul; 60(3):290-4. PubMed ID: 24793966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
